JP2008245536A - Method for producing aldonic acid by lactic acid bacterium - Google Patents
Method for producing aldonic acid by lactic acid bacterium Download PDFInfo
- Publication number
- JP2008245536A JP2008245536A JP2007088046A JP2007088046A JP2008245536A JP 2008245536 A JP2008245536 A JP 2008245536A JP 2007088046 A JP2007088046 A JP 2007088046A JP 2007088046 A JP2007088046 A JP 2007088046A JP 2008245536 A JP2008245536 A JP 2008245536A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- aldonic
- hydroxyl group
- aldonic acid
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 62
- 239000002253 acid Substances 0.000 title claims abstract description 44
- 239000004310 lactic acid Substances 0.000 title claims abstract description 31
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 31
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 29
- 241000894006 Bacteria Species 0.000 title claims abstract description 28
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 claims description 26
- 229940099563 lactobionic acid Drugs 0.000 claims description 25
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 22
- 244000005700 microbiome Species 0.000 claims description 21
- 235000000346 sugar Nutrition 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 13
- 235000015140 cultured milk Nutrition 0.000 claims description 12
- 230000000813 microbial effect Effects 0.000 claims description 12
- 241000194036 Lactococcus Species 0.000 claims description 10
- 235000013336 milk Nutrition 0.000 claims description 8
- 210000004080 milk Anatomy 0.000 claims description 8
- 239000008267 milk Substances 0.000 claims description 7
- 241000194035 Lactococcus lactis Species 0.000 claims 3
- 238000012258 culturing Methods 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 abstract description 6
- 150000001720 carbohydrates Chemical class 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 abstract description 4
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 abstract 1
- 235000014962 Streptococcus cremoris Nutrition 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 28
- 244000057717 Streptococcus lactis Species 0.000 description 22
- 239000000243 solution Substances 0.000 description 19
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 11
- 235000013618 yogurt Nutrition 0.000 description 11
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 239000008101 lactose Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 7
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- -1 for controlling pH Substances 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 3
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 3
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 3
- 150000002772 monosaccharides Chemical class 0.000 description 3
- 125000001477 organic nitrogen group Chemical group 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000589291 Acinetobacter Species 0.000 description 2
- 241001453380 Burkholderia Species 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 150000001323 aldoses Chemical class 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 210000003278 egg shell Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 2
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N Arbutin Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 1
- 241001655328 Bifidobacteriales Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N D-Arabitol Natural products OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000500334 Tetragenococcus Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- CHZVHNZRFPALHO-UHFFFAOYSA-N [Br].[Na] Chemical compound [Br].[Na] CHZVHNZRFPALHO-UHFFFAOYSA-N 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229930195726 aldehydo-L-xylose Natural products 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- FSICMNGKCHFHGP-AMTLMPIISA-N lactobiono-1,5-lactone Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(=O)[C@H](O)[C@H]1O FSICMNGKCHFHGP-AMTLMPIISA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 235000020191 long-life milk Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000010822 slaughterhouse waste Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Dairy Products (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
本発明は、乳酸菌を用いたアルドン酸の製造方法に関するものである。 The present invention relates to a method for producing aldonic acid using lactic acid bacteria.
アルドン酸のひとつであるラクトビオン酸は米国では既にFDAの認可を受け、凝固剤としてプリンのプレミックスに添加されたり、保湿剤として化粧品に利用されている。機能面では、ラクトビオン酸はビフィズス菌選択増殖活性を持ち(例えば、特許文献1参照)、ミネラル吸収促進効果があること(例えば、特許文献2参照)が知られている。また、本発明者らはラクトビオン酸に卵殻強化効果があることを見出し既に特許出願を行った(特願2004−030898号)。このような特性を有するため、ラクトビオン酸を容易にかつ安全性の担保された方法で製造することが特に望まれていた。 Lactobionic acid, one of the aldonic acids, has already been approved by the FDA in the United States and is added to purine premixes as a coagulant or used in cosmetics as a moisturizer. In terms of function, it is known that lactobionic acid has bifidobacterial selective growth activity (for example, see Patent Document 1) and has a mineral absorption promoting effect (for example, see Patent Document 2). Further, the present inventors have found that lactobionic acid has an effect of strengthening eggshell, and have already filed a patent application (Japanese Patent Application No. 2004-030898). Since it has such characteristics, it has been particularly desired to produce lactobionic acid easily and in a manner that ensures safety.
アルドン酸を得るための具体的な方法としては、ヘミアセタール水酸基を有する糖を臭素ナトリウムとともに電気を印加することによって酸化する方法が知られている。また、微生物変換・発酵法により得る方法としては、アシネトバクター属やブルクホルデリア属などの微生物を、ヘミアセタール水酸基を有する糖に作用し酸化することによって得る方法が知られている(例えば、特許文献3参照)。
しかし、アルドン酸の化学合成品は国内の法規制上、食品や飼料用途に使用することができない。また、アシネトバクター属やブルクホルデリア属などの微生物は安全性が十分に担保された菌株とはいえず、これらの微生物を用いて生産したアルドン酸を食品や飼料用途に用いることには問題があった。また、アルドン酸を含有する飲食品は知られていない。 However, chemically synthesized products of aldonic acid cannot be used for food and feed applications due to domestic laws and regulations. In addition, microorganisms such as Acinetobacter and Burkholderia are not sufficiently safe, and there are problems in using aldonic acid produced using these microorganisms for food and feed applications. It was. Moreover, the food / beverage products containing an aldonic acid are not known.
本発明は乳酸菌を用いてアルドン酸を製造する方法を提供することを目的とするものである。 An object of this invention is to provide the method of manufacturing aldonic acid using lactic acid bacteria.
本発明者らは、前記課題を達成するために、微生物について網羅的に検討した結果、乳酸菌がヘミアセタール水酸基を有する糖からアルドン酸を製造することを見出し、本発明に至った。 As a result of exhaustive studies on microorganisms in order to achieve the above-mentioned problems, the present inventors have found that lactic acid bacteria produce aldonic acid from a sugar having a hemiacetal hydroxyl group, and have reached the present invention.
すなわち、本発明の第一は、ヘミアセタール水酸基を有する糖に、乳酸菌に属する微生物の菌体を接触させ、ヘミアセタール水酸基を酸化しアルドン酸を生成することを特徴とするアルドン酸の製造方法を要旨とするものであり、好ましくは、乳酸菌に属する微生物が、ラクトコッカス属に属する微生物であり、さらに好ましくは、ラクトコッカス属に属する微生物が、ラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG−33(FERM P−21207)であるアルドン酸の製造方法である。 That is, the first of the present invention is a method for producing an aldonic acid characterized by contacting a microbial cell belonging to a lactic acid bacterium with a sugar having a hemiacetal hydroxyl group, and oxidizing the hemiacetal hydroxyl group to produce aldonic acid. Preferably, the microorganism belonging to the lactic acid bacterium is a microorganism belonging to the genus Lactococcus, and more preferably, the microorganism belonging to the genus Lactococcus is Lactococcus lactis subspices cremolith KYG-33 ( FERM P-21207) is a method for producing aldonic acid.
また、本発明の第二は、乳酸菌に属する微生物を、ヘミアセタール水酸基を有する糖を含有した培地で培養することにより、培養液中にアルドン酸を蓄積させ、該培養液からアルドン酸を分離することを特徴とするアルドン酸の製造方法を要旨とするものであり、好ましくは、乳酸菌に属する微生物が、ラクトコッカス属に属する微生物であり、さらに好ましくは、ラクトコッカス属に属する微生物が、ラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG−33(FERM P−21207)であるアルドン酸の製造方法である。 In the second aspect of the present invention, a microorganism belonging to a lactic acid bacterium is cultured in a medium containing a sugar having a hemiacetal hydroxyl group, whereby aldonic acid is accumulated in the culture solution and the aldonic acid is separated from the culture solution. The microorganism belonging to the genus Lactococcus is preferably a microorganism belonging to the genus Lactococcus, more preferably the microorganism belonging to the genus Lactococcus is a lactococcus. -It is a manufacturing method of aldonic acid which is Lactis subspecies Cremolis KYG-33 (FERM P-21207).
本発明の第三は、ヘミアセタール水酸基を有する糖からアルドン酸を生産する能力を有するラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG−33(FERM P−21207)を要旨とするものである。 The third aspect of the present invention is summarized as Lactococcus lactis subspecies Cremolis KYG-33 (FERM P-21207) having the ability to produce aldonic acid from a sugar having a hemiacetal hydroxyl group.
さらに本発明の第四は、ラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG−33(FERM P−21207)を乳中で発酵することにより、発酵乳中にラクトビオン酸を生成させることを特徴とするラクトビオン酸高含有発酵乳の製造方法を要旨とするものである。 Furthermore, a fourth aspect of the present invention is a method for producing lactobionic acid in fermented milk by fermenting Lactococcus lactis subspecies Cremolis KYG-33 (FERM P-21207) in milk. The gist of the production method of the acid-rich fermented milk.
本発明によれば、古くから食品製造に使用され安全性の担保された微生物によりアルドン酸を効率よく製造することができ、しかもヘミアセタール水酸基を有する糖の種類に制限されずに対応するアルドン酸を製造することができる。また、アルドン酸を生産する乳酸菌を用いて発酵乳を作成すれば、アルドン酸を含有する発酵乳を得ることができる。 ADVANTAGE OF THE INVENTION According to this invention, aldonic acid can be efficiently manufactured with the microorganisms used for food manufacture from a long time, and the safety | security was ensured, Moreover, it is not restrict | limited to the kind of sugar which has a hemiacetal hydroxyl group, Corresponding aldonic acid Can be manufactured. Moreover, if fermented milk is produced using the lactic acid bacteria which produce aldonic acid, fermented milk containing aldonic acid can be obtained.
以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.
本発明において用いられるヘミアセタール水酸基を有する糖とは、その還元末端がアルデヒドである糖をいう。そのようなものの具体例としては、D−グルコース、D−マンノース、D−ガラクトース、D−リボース、D−キシロース、L−アラビノース等の単糖、セロビオース、マルトース、マルトトリオース、マルトテトラオース、マルトペンタオース、ラクトース等のオリゴ糖があげられる。この中でも好ましくは、D−マンノース、D−ガラクトース、D−リボース、D−キシロース、L−アラビノース、セロビオース、マルトース、マルトトリオース、マルトテトラオース、マルトペンタオース、及びラクトースであり、特に好ましくはラクトースである。 The sugar having a hemiacetal hydroxyl group used in the present invention refers to a sugar whose reducing end is an aldehyde. Specific examples of such compounds include monosaccharides such as D-glucose, D-mannose, D-galactose, D-ribose, D-xylose, L-arabinose, cellobiose, maltose, maltotriose, maltotetraose, malto Examples include oligosaccharides such as pentaose and lactose. Among these, D-mannose, D-galactose, D-ribose, D-xylose, L-arabinose, cellobiose, maltose, maltotriose, maltotetraose, maltopentaose, and lactose are particularly preferable. It is.
本発明においてアルドン酸とは、単糖であるアルドースのヘミアセタール水酸基が酸化されたもののほか、還元末端にアルドース構造を有する二糖以上の糖のヘミアセタール水酸基が酸化されたものも含み、さらにこれらの塩の形態も含むものをいう。また、アルドン酸のうちラクトビオン酸とは、遊離のラクトビオン酸のみならず、ラクトビオン酸塩またはラクトビオノラクトンを含むものである。 In the present invention, aldonic acid includes not only those in which the hemiacetal hydroxyl group of aldose, which is a monosaccharide, is oxidized, but also those in which the hemiacetal hydroxyl group of a sugar having a aldose structure at the reducing end is oxidized, and these The salt form is also included. In addition, lactobionic acid among aldonic acids includes not only free lactobionic acid but also lactobionic acid salt or lactobionolactone.
本発明に用いる乳酸菌は、例えば、ラクトバチルス(Lactobacillus)属、ラクトコッカス(Lactococcus)属、テトラジェノコッカス(Tetragenococcus)属、ペディオコッカス(Pediococcus)属、ビフィドバクテリウム(Bifidobacterium)属、ラクトバチルス・デルブルッキー・サブスピーシズ・ブルガリカス(Lactobacillus delbrueckii subsp. Bulgaricus)、ラクトコッカス・ラクティス(Lactococcus lactis)、ラクトコッカス・ラクティス・サブスピーシーズ・クレモリス(Lactococcus lactis subsp. cremoris)、ストレプトコッカス・サーモフィラス(Streptococcus thermophilus)等があげられ、好ましくはラクトコッカス属である。さらにこれらの乳酸菌のうち、ラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG−33(FERM P−21207)を用いることができる。ラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG−33は、本発明者らが、乳製品中から新規に単離した菌体であり、独立行政法人産業技術総合研究所特許生物寄託センターに受託番号FERM P−21207(受託日:平成19年2月9日)で寄託されている。 The lactic acid bacteria used in the present invention include, for example, Lactobacillus genus, Lactococcus genus, Tetragenococcus genus, Pediococcus genus, Bifidobacterium genus, Lactobacillus genus・ Brugaricus (Lactobacillus delbrueckii subsp.Bulgaricus), Lactococcus lactis, Lactococcus lactis subsp. Preferably, it is a genus Lactococcus. Furthermore, among these lactic acid bacteria, Lactococcus lactis subspecies Cremolis KYG-33 (FERM P-21207) can be used. Lactococcus lactis sub-species Cremolis KYG-33 is a cell body newly isolated by the present inventors from dairy products, and has the accession number FERM at the National Institute of Advanced Industrial Science and Technology Patent Organism Depositary. It is deposited at P-21207 (date of deposit: February 9, 2007).
ラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG−33(FERM P−21207)の菌学的特性は、下記に示すとおりである。
(形態的特性)
培養温度:30℃
形状:球菌
大きさ:0.9―1.0μm
運動性の有無:なし
胞子の形成:なし
(培養的性質)
色調:クリーム色
コロニー形態:円形
隆起状態:レンズ状
周縁:全縁
表面:スムーズ
透明度:不透明
粘稠度:バター様
(生理学的性質)
グラム染色:+
カタラーゼ:−
オキシダーゼ:−
O/F試験:+
40℃での生育:−
4%NaClでの生育:−
(発酵試験)
グリセロール:−
エリスリトール:−
D-アラビノース:−
L-アラビノース:−
リボース:−
D-キシロース:−
L-キシロース:−
アドニトール:−
β-メチル-D-キシロシド:−
ガラクトース:+
グルコース:+
フラクトース:+
マンノース:+
ソルボース:−
ラムノース:−
ズルシトール:−
イノシトール:−
マンニトール:−
α-メチル-D-マンノシド:−
α-メチル-D-グルコシド:−
N-アセチルグルコサミン:+
アミグダリン:−
アルブチン:−
エスクリン:+
サリシン:+
セロビオース:+
マルトース:+
ラクトース:+
メリビオース:−
サッカロース:−
トレハロース:+
イヌリン:−
メレチトース:−
ラフィノース:−
でんぷん:−
グリコーゲン:−
キシリトール:−
ゲンチオビオース:+
D-ツラノース:−
D-リキソース:−
D-タガトース:−
D-フコース:−
L-フコース:−
D-アラビトール:−
L-アラビトール:−
グルコネート:−
2-ケトグルコネート:−
5-ケトグルコネート:−
上記のような本菌株の菌学的性質と、16S rDNA塩基配列をGenBank/DDBJ/EMBLにより相同性検索した結果から、本菌株はL. lactisに帰属し、亜種レベルではL. lactis subsp. cremorisに帰属する可能性が最も高いと考えられた。しかしながら、後述するようにラクトビオン酸の産生能の点で公知のL. lactis subsp. Cremorisと相異が認められたため、新菌株として寄託を行なった。
The mycological characteristics of Lactococcus lactis subspecies Cremolis KYG-33 (FERM P-21207) are as shown below.
(Morphological characteristics)
Culture temperature: 30 ° C
Shape: Cocci Size: 0.9-1.0μm
Existence of motility: None Spore formation: None (culture characteristics)
Color: Cream colony Morphology: Circular ridged state: Lenticular rim: Full edge surface: Smooth transparency: Opaque consistency: Butter-like (physiological properties)
Gram staining: +
Catalase:-
Oxidase:-
O / F test: +
Growth at 40 ° C:-
Growth with 4% NaCl: −
(Fermentation test)
Glycerol:-
Erythritol:-
D-arabinose:-
L-arabinose:-
Ribose:-
D-xylose:-
L-xylose:-
Adonitol:-
β-methyl-D-xyloside: −
Galactose: +
Glucose: +
Fructose: +
Mannose: +
Sorbose:-
Rhamnose:-
Dulcitol:-
Inositol:-
Mannitol:-
α-methyl-D-mannoside: −
α-methyl-D-glucoside: −
N-acetylglucosamine: +
Amygdalin:-
Arbutin:-
Esclin: +
Salicin: +
Cellobiose: +
Maltose: +
Lactose: +
Melibiose:-
Sucrose:-
Trehalose: +
Inulin:-
Meletetose:-
Raffinose:-
Starch:-
Glycogen:-
Xylitol:-
Gentiobiose: +
D-Tulanose:-
D-lyxose:-
D-Tagatose:-
D-Fucose:-
L-Fucose:-
D-arabitol:-
L-arabitol:-
Gluconate:-
2-ketogluconate:-
5-ketogluconate:-
From the bacteriological properties of the strain and the results of homology search of 16S rDNA base sequence by GenBank / DDBJ / EMBL, the strain belongs to L. lactis, and at the subspecies level, L. lactis subsp. The most likely attributed to cremoris. However, as described later, since it was different from the known L. lactis subsp. Cremoris in terms of the ability to produce lactobionic acid, it was deposited as a new strain.
このように自然界から分離した乳酸菌を用いることもできるが、東京大学 分子細胞生物学研究所や独立行政法人製品評価技術基盤機構の様に、いずれの人の要求に対しても分譲できるような公的な寄託機関によって保存されている菌株を使用することもできる。それらには、例えば、ラクトコッカス・ラクティス・サブスピーシーズ・クレモリス NBRC100676( Lactococcus lactis subsp. cremoris NBRC100676) やラクトバチルス・デルベッキ・サブスピーシーズ・デルベッキIAM12076(Lactobacillus delbrueckii subsp. delbrueckii IAM12076)やラクトバチルス・ラクティス・サブスピーシーズ・ラクティスIAM10070(Lactobacillus lactis subsp. lactis IAM10070)などが挙げられる。 Lactic acid bacteria isolated from the natural world can be used in this way, but public institutions that can be distributed to any person's demand, such as the Institute for Molecular Cell Biology and the National Institute for Product Evaluation Technology, the University of Tokyo. It is also possible to use strains conserved by traditional depository institutions. These include, for example, Lactococcus lactis subspices cremolith NBRC100676 (Lactococcus lactis subsp. Examples include Lactobacillus lactis subsp. Lactis IAM10070.
本発明の第一の製造方法は、ヘミアセタール水酸基を有する糖に、乳酸菌の菌体を接触させ、菌体中または細胞膜上の酵素によってヘミアセタール水酸基を有する糖を酸化しアルドン酸を生成する方法である。本発明で用いられる乳酸菌の菌体としては、乳酸菌の生菌体そのまま、あるいは菌体処理物又はそれらを担体に固定化したものがあげられる。 The first production method of the present invention is a method for producing an aldonic acid by contacting a lactic acid bacterial cell with a sugar having a hemiacetal hydroxyl group, and oxidizing the sugar having a hemiacetal hydroxyl group by an enzyme in the bacterial cell or on a cell membrane. It is. Examples of the lactic acid bacteria used in the present invention include live lactic acid bacteria as they are, processed microbial cells, or those immobilized on a carrier.
先ず乳酸菌の菌体を得るには、培養を行なう必要がある。培地としては、通常の微生物と同様に培養することができる。微生物が通常資化しうる炭素源、窒素源、ビタミン、ミネラルなどの成分を適宜配合したものが用いられる。炭素源としては、グルコース、果糖などの単糖類、ショ糖、麦芽糖などのオリゴ糖類、多糖類、糖アルコール、グリセロールなどが挙げられ、一般的な炭水化物としては、トウモロコシ澱粉、モルトなどがあり、さらには、オリーブ油、コーン油、などの植物油も炭素源にふくめられる。また、CSL(コーンスティーブリカー)や、大豆フレークを用いてもよい。その他、アルコール、有機酸、アルカンの様な炭素化合物でもよい。 First, in order to obtain bacterial cells of lactic acid bacteria, it is necessary to perform culture. The medium can be cultured in the same manner as normal microorganisms. What mixed suitably components, such as a carbon source, a nitrogen source, a vitamin, and a mineral which can be normally utilized by microorganisms, is used. Examples of carbon sources include monosaccharides such as glucose and fructose, oligosaccharides such as sucrose and maltose, polysaccharides, sugar alcohols, and glycerol. Common carbohydrates include corn starch and malt. Vegetable oils such as olive oil and corn oil are also included in the carbon source. Also, CSL (corn steep liquor) or soybean flakes may be used. In addition, carbon compounds such as alcohol, organic acid, and alkane may be used.
窒素源としては、無機、有機どちらの窒素も利用できるが、無機態の窒素はアンモニア塩、硝酸体などを用いる。有機窒素はアミノ酸、たんぱく質または尿素の形で与えられる。天然の有機窒素複合体としては、CSL、大豆や、大豆フレーク、ピーナッツミール、綿花ミール、ディスティラーズソルブル(Distillers’solubles)、カゼイン水解物、屠殺場廃棄物、魚粉、酵母エキスなどを使用する。 As the nitrogen source, both inorganic and organic nitrogen can be used, but as the inorganic nitrogen, ammonia salt, nitric acid or the like is used. Organic nitrogen is provided in the form of amino acids, proteins or urea. Natural organic nitrogen complexes include CSL, soybeans, soybean flakes, peanut meal, cotton meal, Distillers'solubles, casein hydrolyzate, slaughterhouse waste, fish meal, yeast extract, etc. .
ビタミンとしては、天然の炭素源、窒素源を用いることで微生物の生育にとって必要なビタミン類は十分に補給できるが、パントテン酸カルシウムや、ビオチン、ビタミンB1などを必要に応じて添加する。 As vitamins, vitamins necessary for the growth of microorganisms can be sufficiently supplemented by using natural carbon sources and nitrogen sources, but calcium pantothenate, biotin, vitamin B1 and the like are added as necessary.
ミネラルとしては、マグネシウム、カリウム、カルシウムが必要であるが、さらに、コバルト、銅、鉄、マンガン、モリブデン、亜鉛なども微量ながら必要である。 As minerals, magnesium, potassium, and calcium are required, but cobalt, copper, iron, manganese, molybdenum, zinc, and the like are also required in a trace amount.
その他の成分としては、pHのコントロールのために、培養液中に炭酸カルシウムを添加したり、緩衝作用を持たせるために、リン酸塩などを加えてもよい。また、培養系のpHを制御するために、アンモニアや、苛性ソーダ、塩酸、硫酸などを添加してよい。 As other components, for controlling pH, calcium carbonate may be added to the culture solution, or phosphate may be added for buffering. In order to control the pH of the culture system, ammonia, caustic soda, hydrochloric acid, sulfuric acid or the like may be added.
培養は、使用する菌株の最適培養条件で行うことが好ましいが、概略、温度としては、20〜35℃が好適であり、pHとしては、塩酸、水酸化ナトリウム水溶液や炭酸カルシウムなどによりpH4〜8に維持することが好ましい。 The culture is preferably performed under the optimal culture conditions for the strain to be used. In general, the temperature is preferably 20 to 35 ° C, and the pH is 4 to 8 with hydrochloric acid, aqueous sodium hydroxide, calcium carbonate, or the like. Is preferably maintained.
培養方法としては静置培養、振とう培養、深部通気撹拌培養があげられる。大量培養の場合、回分法、逐次添加培養法、連続培養法を用いた深部通気撹拌培養が好ましい。このような条件で培養を行うと、培養から15〜168時間で十分な量の微生物が得られる。 Examples of the culture method include stationary culture, shaking culture, and deep aeration and agitation culture. In the case of mass culture, deep aeration and agitation culture using a batch method, a sequential addition culture method, or a continuous culture method is preferable. When the culture is performed under such conditions, a sufficient amount of microorganisms can be obtained in 15 to 168 hours after the culture.
上記のようにして得られた乳酸菌の生菌体をそのまま用いる場合は、回収、洗浄した菌体をそのまま用いることができる。 When the live microbial cells obtained as described above are used as they are, the recovered and washed cells can be used as they are.
乳酸菌の菌体処理物として用いる場合は、アセトン、第四アンモニウム化合物、硫酸ラウリルソーダ、Tweenまたは、微生物の細胞壁の特異的な結合を分解する酵素などで処理した菌体、凍結した菌体を減圧下で水分を昇華することで得られる凍結乾燥菌体、ホモジナイザーやガラスビーズを用い、物理的に破砕した菌体破砕物や菌体膜画分、さらには菌体破砕物の上清である無細胞抽出物、これらから酵素を抽出した粗酵素液などを用いることができる。 When used as a treated product of lactic acid bacteria, the cells treated with acetone, quaternary ammonium compounds, lauryl sulfate, Tween, or an enzyme that breaks down the specific binding of the cell walls of microorganisms, or frozen cells are decompressed. Freeze-dried microbial cells obtained by sublimation of moisture under the water, homogenizers and glass beads, and crushed microbial cells and cell membrane fractions, as well as the supernatant of microbial cell lysates Cell extracts, crude enzyme solutions obtained by extracting enzymes from these, and the like can be used.
乳酸菌の菌体あるいは処理物を担体に固定化するには、セルロース担体、セラミック担体、ガラスビーズ担体のような物質に吸着させる方法や、格子構造を持つゲル状物質、たとえば寒天、アルギン酸カルシウム、カラギーナンや、公知のポリマーに包括する方法などが挙げられる。これらの方法は糖酸化活性を有する乳酸菌の菌体や菌体処理物を繰り返し使用することを可能にする。 In order to immobilize lactic acid bacterial cells or treated products on a carrier, a method of adsorbing to a substance such as a cellulose carrier, a ceramic carrier or a glass bead carrier, or a gel-like substance having a lattice structure such as agar, calcium alginate, carrageenan, etc. And a method encompassed by known polymers. These methods make it possible to repeatedly use lactic acid bacteria having a oxidization activity and treated cells.
本発明の第一の製造方法においては、基質となるヘミアセタール水酸基を有する糖を反応溶媒に溶解し、上記したように調製した乳酸菌の培養液、菌体、菌体処理物、又は菌体や菌体処理物を担体に固定化したものを加えて必要により反応温度、反応液のpHを制御しながら反応させる。反応溶媒としては、イオン交換水、緩衝液などの水性溶媒が使用できる。反応液の基質濃度は特に制限はないが、基質となる前記糖の溶解度、生産性などを考慮すると10〜50質量%で実施するのが好ましい。 In the first production method of the present invention, a saccharide having a hemiacetal hydroxyl group serving as a substrate is dissolved in a reaction solvent, and a lactic acid bacterium culture solution, a microbial cell, a processed microbial cell, or a microbial cell prepared as described above A product obtained by immobilizing a cell-treated product on a carrier is added, and the reaction is carried out while controlling the reaction temperature and pH of the reaction solution as necessary. As the reaction solvent, an aqueous solvent such as ion-exchanged water or a buffer solution can be used. The substrate concentration of the reaction solution is not particularly limited, but it is preferably 10 to 50% by mass in consideration of the solubility and productivity of the sugar as a substrate.
反応時間に特に制限はないが、通常6〜24時間、好ましくは6〜12時間で反応が終了する条件を選択することが好ましい。反応pHは、用いる乳酸菌の酵素の至適pHに依存するが、一般的にはpH4〜8の範囲で、特に5〜7が好ましい。また、反応温度は微生物酵素が失活しない条件であればよく、20〜60℃が好ましいが、25〜45℃がより好ましい。 Although there is no restriction | limiting in particular in reaction time, It is preferable to select the conditions which reaction completes normally in 6 to 24 hours, preferably 6 to 12 hours. The reaction pH depends on the optimum pH of the enzyme of the lactic acid bacterium to be used, but is generally in the range of pH 4 to 8, and 5 to 7 is particularly preferable. Moreover, the reaction temperature should just be the conditions which a microbial enzyme does not deactivate, 20-60 degreeC is preferable, but 25-45 degreeC is more preferable.
反応方法としては静置、振とう、深部通気撹拌があげられるが、好気的に反応させることがアルドン酸の収量を上げる上で好都合である。このような条件で培養を行うと、6〜24時間で十分な量の生産物が得られる。 Examples of the reaction method include standing, shaking, and deep aeration stirring, but it is convenient to aerobically react to increase the yield of aldonic acid. When culture is performed under such conditions, a sufficient amount of product can be obtained in 6 to 24 hours.
以上のようにして得られた反応液から、目的とするアルドン酸を単離精製するには、抽出、カラム分離などの一般的な分離方法を用いることができる。例えば、エタノールを反応液に添加して、目的産物を沈殿し回収する方法、活性炭や、多孔性有機樹脂粒子を用いた吸着クロマトグラフィーや、ゲルろ過、イオン交換樹脂クロマトグラフィーを用いて単離することができる。 In order to isolate and purify the target aldonic acid from the reaction solution obtained as described above, a general separation method such as extraction or column separation can be used. For example, ethanol is added to the reaction solution, and the target product is precipitated and collected, and is isolated using activated carbon, adsorption chromatography using porous organic resin particles, gel filtration, or ion exchange resin chromatography. be able to.
また、本発明の第二の製造方法は、乳酸菌を、ヘミアセタール水酸基を有する糖を含有した培地で培養することにより、培養液中にアルドン酸を蓄積させ、培養液からアルドン酸を分離するものである。培養に用いられる培地成分としては、培地中にヘミアセタール水酸基を有する糖を含有させる以外は、本発明の第一の製造方法で菌体を得るための培養に用いる上記した培地成分が同様に用いられる。ヘミアセタール水酸基を有する糖の含有量としては、0.1〜500g/L、好ましくは、0.5〜200g/L、さらに好ましくは、0.5〜150g/Lである。 In the second production method of the present invention, lactic acid bacteria are cultured in a medium containing a sugar having a hemiacetal hydroxyl group, whereby aldonic acid is accumulated in the culture solution and aldonic acid is separated from the culture solution. It is. As the medium components used for the culture, the above-mentioned medium components used for the culture for obtaining the cells by the first production method of the present invention are used in the same manner except that the medium contains a sugar having a hemiacetal hydroxyl group. It is done. The content of the sugar having a hemiacetal hydroxyl group is 0.1 to 500 g / L, preferably 0.5 to 200 g / L, and more preferably 0.5 to 150 g / L.
また、培養条件としては、培養期間が通常1〜10日間であることを除いて、前記した培養条件と同様に行うことができる。 The culture conditions can be the same as the culture conditions described above except that the culture period is usually 1 to 10 days.
培養液中に蓄積したアルドン酸は、前述した方法と同様に分離、精製することができる。 Aldonic acid accumulated in the culture solution can be separated and purified in the same manner as described above.
本発明の第四は、ラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG―33(FERM P−21207)を用いて、乳からラクトビオン酸高含有発酵乳を製造する方法である。 A fourth aspect of the present invention is a method for producing fermented milk having a high lactobionic acid content from milk using Lactococcus lactis subspecies Cremolis KYG-33 (FERM P-21207).
この発明で用いられる乳としては、牛乳、ヤギ乳などがあげられ、新鮮なものが好ましくあらかじめ殺菌するのが望ましい。また、本発明で用いられる乳としては、脱脂粉乳やホエーなど乳糖を含んでいる食品であってもよい。これらの乳に、必要に応じ、ショ糖、果糖、転化糖、ブドウ糖等の糖類、水、果肉、果汁、香料、酸味料等を適宜加えることができる。 Examples of the milk used in the present invention include cow's milk and goat milk, and fresh ones are preferably sterilized in advance. Moreover, as milk used by this invention, the foodstuffs containing lactose, such as skim milk powder and whey, may be sufficient. If necessary, sugars such as sucrose, fructose, invert sugar and glucose, water, pulp, fruit juice, flavor, acidulant and the like can be appropriately added to these milks.
乳に添加する乳酸菌は、ラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG―33(FERM P−21207)であり、この菌体をそのまま、あるいは菌体を脱脂粉乳培地に添加した後凍結乾燥することにより粉末状の種菌、いわゆるヨーグルト種菌にした上で添加してもよい。 Lactic acid bacteria to be added to milk is Lactococcus lactis subspecies Cremolis KYG-33 (FERM P-21207), and the cells are added as they are to the nonfat dry milk medium and then freeze-dried. Powdered inoculum, so-called yogurt inoculum, may be added.
発酵の条件としては、20〜50℃、好ましくは25〜40℃、さらに好ましくは25〜30℃の温度条件下、静置培養を行なえば、3〜72時間程度でラクトビオン酸高含有発酵乳が得られる。 As conditions for fermentation, 20 to 50 ° C., preferably 25 to 40 ° C., and more preferably 25 to 30 ° C. can get.
そして、上記方法で製造した発酵乳は、ヨーグルト(ハードヨーグルト、ソフトヨーグルト、ドリンクヨーグルト、フローズンヨーグルト、殺菌ヨーグルト、プレーンヨーグルト、加糖ヨーグルトを含む)に限定されるものではなく、これを各種加工し、各種飲食品に関与させた形態としたものであってもよい。上記飲食品としては、例えば、乳酸飲料、アイスキャンデーなどの冷菓、プリン、ゼリー、シュークリーム、ケーキ等の生菓子、ラムネ、アメ、チョコレート、ビスケット等の菓子、チーズ、バター、パン、シチュー、ドレッシングやその他の飲食品あるいは健康食品があげられる。 The fermented milk produced by the above method is not limited to yogurt (including hard yogurt, soft yogurt, drink yogurt, frozen yogurt, sterilized yogurt, plain yogurt, and sweetened yogurt). You may be made into the form related to various food-drinks. Examples of the food and drink include frozen confectionery such as lactic acid beverages and popsicles, raw confectionery such as pudding, jelly, cream puff and cake, confectionery such as ramune, candy, chocolate and biscuits, cheese, butter, bread, stew, dressing and others Food and drink or health food.
本発明の製造方法により製造されたアルドン酸、なかでもラクトビオン酸は、整腸作用、脂質代謝改善作用、ミネラル吸収促進作用、卵殻強化作用を示し、医薬品、飲食品や、飼料として有用である。上記アルドン酸、なかでもラクトビオン酸を医薬品として用いる場合は、当該分野で常套的に用いられている賦形剤、潤沢剤、希釈剤、pH調節剤、防腐剤、甘味剤、芳香剤、乳化分散剤などを用いて錠剤、粉剤、水和剤、乳剤として経口的にまたは非経口的に投与することができる。また、上記アルドン酸、なかでもラクトビオン酸を飲食品や、飼料として用いる場合、そのままで、または他の飲食品や飼料に添加もしくは混合して使用することができる。 The aldonic acid produced by the production method of the present invention, especially lactobionic acid, exhibits an intestinal regulating action, a lipid metabolism improving action, a mineral absorption promoting action, and an eggshell strengthening action, and is useful as a medicine, food and drink, and feed. When using the above-mentioned aldonic acid, especially lactobionic acid as a pharmaceutical, excipients, lubricants, diluents, pH regulators, preservatives, sweeteners, fragrances, emulsifying dispersions conventionally used in the field It can be administered orally or parenterally as tablets, powders, wettable powders and emulsions. Moreover, when using the said aldonic acid, especially lactobionic acid as food / beverage products and feed, it can be used as it is, or it can be added or mixed with other food / beverage products and feed.
以下、実施例によって本発明を具体的に説明するが、本発明はこれらの例のみに限定されるものではない。なお、実施例中、%は、質量%を表す。 EXAMPLES Hereinafter, although an Example demonstrates this invention concretely, this invention is not limited only to these examples. In the examples,% represents mass%.
実施例において、反応液中あるいは培養液中のラクトビオン酸の定量は高速液体クロマトグラフィー(HPLC)を用い以下の条件により行なった。
HPLC分析条件
カラムAsahipak NH2P−50(昭和電工社製)
溶離液 アセトニトリル:40mMクエン酸−NaH2PO4緩衝液(pH5.0)=60:40(体積比)
条件 温度:40℃
流速:0.8mL/mL
検出器:示差屈折計
In Examples, lactobionic acid in a reaction solution or a culture solution was quantified using high performance liquid chromatography (HPLC) under the following conditions.
HPLC analysis condition column Asahipak NH2P-50 (Showa Denko)
Eluent Acetonitrile: 40 mM citrate-NaH 2 PO 4 buffer (pH 5.0) = 60: 40 (volume ratio)
Condition Temperature: 40 ℃
Flow rate: 0.8mL / mL
Detector: Differential refractometer
実施例1〜4〔菌体を接触させてのラクトビオン酸の生産〕
〔菌体の調製〕
試験管(18 mm×200 mm)に、ラクトース0.5%、グルコース0.5%、酵母エキス0.5%、ポリペプトン0.5%、硫酸マグネシウム0.1%(pH7.0)を含む培地3mLを分注し、121℃で20分間殺菌した。その試験管にラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG−33(FERM P−21207)(実施例1)及び独立行政法人製品評価技術基盤機構や東京大学分子細胞生物学研究所から入手した乳酸菌(実施例2、3、4)の一白金耳を植菌し、27℃で3日間振とう培養(220rpm)した。その後、培養液を遠心し菌体を回収した。
〔ラクトビオン酸の生産〕
上記の方法で得られた菌体の全量を2%ラクトース1mLに再懸濁し、27度で3日間振とうし、反応液中のラクトビオン酸を測定した。結果を表1に示す。
Examples 1 to 4 [Production of lactobionic acid by contacting cells]
[Preparation of bacterial cells]
In a test tube (18 mm × 200 mm), dispense 3 mL of medium containing 0.5% lactose, 0.5% glucose, 0.5% yeast extract, 0.5% polypeptone, and 0.1% magnesium sulfate (pH 7.0). Sterilized for a minute. In the test tube, Lactococcus lactis sub-species Cremolis KYG-33 (FERM P-21207) (Example 1) and lactic acid bacteria obtained from the Institute for Molecular Cell Biology (National Institute for Molecular and Cell Biology) One platinum loop of Examples 2, 3, and 4) was inoculated, and cultured with shaking (220 rpm) at 27 ° C. for 3 days. Thereafter, the culture broth was centrifuged to collect the cells.
[Production of lactobionic acid]
The whole amount of the cells obtained by the above method was resuspended in 1 mL of 2% lactose, shaken at 27 degrees for 3 days, and lactobionic acid in the reaction solution was measured. The results are shown in Table 1.
実施例5〔各種アルドン酸の生産〕
実施例1と同様にして、ラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG−33(FERM P−21207)の菌体を調製し、ヘミアセタール水酸基を有する糖12種(D−マンノース、D−ガラクトース、D−リボース、D−キシロース、L−アラビノース、セロビオース、マルトース、マルトトリオース、マルトテトラオース、マルトペンタオース、ラクトース)の2%水溶液1mLに再懸濁し、27度で3日間振とうした。反応液中に含まれる各種アルドン酸の定量結果を表2に示した。
Example 5 [Production of various aldonic acids]
In the same manner as in Example 1, cells of Lactococcus lactis subspecies Cremolis KYG-33 (FERM P-21207) were prepared, and 12 types of sugars having a hemiacetal hydroxyl group (D-mannose, D-galactose, D-ribose, D-xylose, L-arabinose, cellobiose, maltose, maltotriose, maltotetraose, maltopentaose, lactose) were resuspended in 1 mL of a 2% aqueous solution and shaken at 27 degrees for 3 days. Table 2 shows the quantitative results of various aldonic acids contained in the reaction solution.
実施例6〔ラクトースを含む培地によるラクトビオン酸の生産〕
〔前培養〕
試験管(18 mm×200 mm)に、グルコース0.5%、酵母エキス0.5%、ポリペプトン0.5%、硫酸マグネシウム0.1%(pH7.0)を含む培地3mLを分注し、121℃で20分間殺菌した。その試験管に一白金耳のラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG−33(FERM P−21207)を植菌し、27℃で1晩振とう培養(220rpm)した。次に上記組成培地を1L分注し121℃で20分間殺菌した3L三角フラスコに上記試験管培養液を植菌し30℃で3日間振とう培養(220rpm)した。
Example 6 [Production of lactobionic acid by a medium containing lactose]
[Pre-culture]
A test tube (18 mm × 200 mm) was dispensed with 3 mL of medium containing 0.5% glucose, 0.5% yeast extract, 0.5% polypeptone, and 0.1% magnesium sulfate (pH 7.0), and sterilized at 121 ° C. for 20 minutes. One platinum loop of Lactococcus lactis subspecies Cremolis KYG-33 (FERM P-21207) was inoculated into the test tube, and cultured overnight at 27 ° C. with shaking (220 rpm). Next, 1 L of the above-mentioned composition medium was dispensed, and the test tube culture solution was inoculated into a 3 L Erlenmeyer flask sterilized at 121 ° C. for 20 minutes, followed by shaking culture (220 rpm) at 30 ° C. for 3 days.
〔本培養〕
ジャーファーメンターによる培養を行った。グルコース1.5%、ラクトース15%、酵母エキス0.5%、ポリペプトン0.5%、硫酸マグネシウム0.1%、炭酸カルシウム7.5%を含む培地(pH7.0)を20L調製し121℃で20分間殺菌した。これに上記前培養液1Lを植菌し、30℃で深部撹拌培養(300回転、1vvm)をした。培養液中に蓄積したラクトビオン酸濃度を図1に示す。
[Main culture]
Cultivation was performed using a jar fermenter. 20 L of a medium (pH 7.0) containing 1.5% glucose, 15% lactose, 0.5% yeast extract, 0.5% polypeptone, 0.1% magnesium sulfate and 7.5% calcium carbonate was prepared and sterilized at 121 ° C. for 20 minutes. This was inoculated with 1 L of the above precultured solution and subjected to deep stirring culture (300 rpm, 1 vvm) at 30 ° C. The concentration of lactobionic acid accumulated in the culture solution is shown in FIG.
実施例7、比較例1,2〔ラクトビオン酸高含有発酵乳の製造〕
〔乳酸菌の培養〕
500mLの三角フラスコに、Lactobacilli MRS Broth(デフィコ社)100mLを入れ121℃で20分間殺菌した。そこに一白金耳のラクトコッカス・ラクティス・サブスピーシーズ・クレモリスKYG−33(FERM P−21207)(実施例7)、ラクトコッカス・ラクティス・サブスピーシーズ・クレモリス NBRC100676(比較例1)ラクトコッカス・ラクティス・サブスピーシーズ・ラクティス IAM10070(比較例2)を植菌し27℃で2日間静置培養した。
Example 7, Comparative Examples 1 and 2 [Production of Fermented Milk High in Lactobionic Acid]
[Cultivation of lactic acid bacteria]
A 500 mL Erlenmeyer flask was charged with 100 mL of Lactobacilli MRS Broth (Defico) and sterilized at 121 ° C. for 20 minutes. There is one platinum ear Lactococcus lactis subspecies cremolith KYG-33 (FERM P-21207) (Example 7), Lactococcus lactis subspecies cremolith NBRC100676 (comparative example 1) Lactococcus lactis Subspecies lactis IAM10070 (Comparative Example 2) was inoculated and cultured at 27 ° C. for 2 days.
〔ヨーグルト種菌の調製〕
培養した乳酸菌を脱脂粉乳培地に添加し凍結乾燥により粉末状にすることにより、粉末状の種菌を得た。
〔ラクトビオン酸高含有発酵乳の作製〕
殺菌済みの容器の中に、殺菌済みの新鮮な牛乳100mlを入れた。そこに、調製したヨーグルト種菌を10g添加した。蓋をして閉め、27℃で24時間放置した。このようにして作製された発酵乳をサンプリングしラクトビオン酸含量を測定した。発酵乳中のラクトビオン酸含量を表3に示した。
[Preparation of yogurt inoculum]
The cultured lactic acid bacteria were added to the skim milk medium and powdered by lyophilization to obtain a powdered inoculum.
[Production of fermented milk with high lactobionic acid content]
In a sterilized container, 100 ml of fresh sterilized milk was placed. 10 g of the prepared yogurt inoculum was added thereto. The lid was closed and left at 27 ° C. for 24 hours. The fermented milk thus prepared was sampled and the lactobionic acid content was measured. The lactobionic acid content in the fermented milk is shown in Table 3.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007088046A JP5420153B2 (en) | 2007-03-29 | 2007-03-29 | Method for producing aldonic acid by lactic acid bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007088046A JP5420153B2 (en) | 2007-03-29 | 2007-03-29 | Method for producing aldonic acid by lactic acid bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008245536A true JP2008245536A (en) | 2008-10-16 |
JP5420153B2 JP5420153B2 (en) | 2014-02-19 |
Family
ID=39971246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007088046A Active JP5420153B2 (en) | 2007-03-29 | 2007-03-29 | Method for producing aldonic acid by lactic acid bacteria |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5420153B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011153090A (en) * | 2010-01-27 | 2011-08-11 | Unitika Ltd | Agent for preventing and improving skin aging |
JP2012005401A (en) * | 2010-06-24 | 2012-01-12 | San-Ei Sucrochemical Co Ltd | Method of producing carboxylic acid and/or carbohydrate carboxylic acid and/or salt thereof belonging to genus pantoea |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS626649A (en) * | 1985-07-02 | 1987-01-13 | Shikoku Kakoki Co Ltd | Production of fermented sparkling soya milk drink using bean curd refuse |
JPH03201949A (en) * | 1989-12-29 | 1991-09-03 | Asahi Breweries Ltd | Production of fermented beer lees for feed |
JPH0630781A (en) * | 1992-07-10 | 1994-02-08 | Meiji Milk Prod Co Ltd | Method for integrating gene to chromosome of species lactobacillus delbrueckii and gene integrated material |
WO2005085418A1 (en) * | 2004-03-04 | 2005-09-15 | Biobalance Co., Ltd. | Novel lactic acid bacterium |
WO2006033333A1 (en) * | 2004-09-24 | 2006-03-30 | Kaneka Corporation | Method of producing aldonic acids and aldose dehydrogenase |
-
2007
- 2007-03-29 JP JP2007088046A patent/JP5420153B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS626649A (en) * | 1985-07-02 | 1987-01-13 | Shikoku Kakoki Co Ltd | Production of fermented sparkling soya milk drink using bean curd refuse |
JPH03201949A (en) * | 1989-12-29 | 1991-09-03 | Asahi Breweries Ltd | Production of fermented beer lees for feed |
JPH0630781A (en) * | 1992-07-10 | 1994-02-08 | Meiji Milk Prod Co Ltd | Method for integrating gene to chromosome of species lactobacillus delbrueckii and gene integrated material |
WO2005085418A1 (en) * | 2004-03-04 | 2005-09-15 | Biobalance Co., Ltd. | Novel lactic acid bacterium |
WO2006033333A1 (en) * | 2004-09-24 | 2006-03-30 | Kaneka Corporation | Method of producing aldonic acids and aldose dehydrogenase |
Non-Patent Citations (1)
Title |
---|
JPN6012021284; J. Appl. Glycosci., 51[2](2004) p.149-154 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011153090A (en) * | 2010-01-27 | 2011-08-11 | Unitika Ltd | Agent for preventing and improving skin aging |
JP2012005401A (en) * | 2010-06-24 | 2012-01-12 | San-Ei Sucrochemical Co Ltd | Method of producing carboxylic acid and/or carbohydrate carboxylic acid and/or salt thereof belonging to genus pantoea |
Also Published As
Publication number | Publication date |
---|---|
JP5420153B2 (en) | 2014-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1327720C (en) | Method for producing processed milk containing galactooligosaccharide | |
Vuyst et al. | Production by and isolation of exopolysaccharides from Streptococcus thermophilus grown in a milk medium and evidence for their growth‐associated biosynthesis | |
Danova et al. | Isolation and characterization of Lactobacillus strains involved in koumiss fermentation | |
AU2003249081B2 (en) | Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions | |
EP2478910B1 (en) | Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance | |
JP3017687B2 (en) | Bifidobacterium and culture method thereof | |
JP5100987B2 (en) | Method for producing aldonic acid | |
US20110123640A1 (en) | Novel fermented milk product and use thereof | |
CN109890954B (en) | Lactic acid bacterium having hyaluronic acid production promoting ability | |
JP5420153B2 (en) | Method for producing aldonic acid by lactic acid bacteria | |
JP5346764B2 (en) | Production method of hyaluronic acid | |
EP2837292B1 (en) | Synbiotic food composition containing tagatose and probiotic lactic acid bacteria | |
JP3875237B2 (en) | Bifidobacterium longum | |
TWI784019B (en) | Method for producing galactooligosaccharides | |
JP5603036B2 (en) | Probiotic growth promoter | |
JP2008245587A (en) | Method for producing lactobionic acid-containing milk beverage | |
KR20020072807A (en) | Novel lactobacillus sp. strain having the effect of immune enhancement | |
KR100725012B1 (en) | The new lactobacillus acidophilus HY 7036 isolated from korean adult, having high constipation improvement effect, high relieving intestinal disorders and high organic acid producibility, and products containing it | |
JP2008278776A (en) | Method for producing lactobionic acid-containing fermented milk | |
KR101804778B1 (en) | Lactobacillus plantarum HY7716 having production capability of the rare sugar allulose, and Products containing thereof as effective component | |
Petrova et al. | Thermotolerant yeast strains producers of galacto-oligosaccharides | |
JP2008173065A (en) | Method for producing aldonic acid | |
KR0142615B1 (en) | New Lactic Acid Bacteria with Excellent Acid Resistance and Cholesterol Degradation Isolated from Feces of Korean Infant and Their Use | |
El-Shafei et al. | Production of high quality functional Labneh cheese using exopolysaccharides producing encapsulated Lactobacillus bulgaricus | |
JP2007001973A (en) | New oligosaccharide, food added with new oligosaccharide, method for producing the same, noncarious food composition and bifidus bacterium proliferation composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20081006 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20081007 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100319 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120508 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120706 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20120706 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120711 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130402 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130531 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130813 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131015 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131105 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131120 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5420153 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |